Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

Area of Science:

• Endocrinology
• Genetics
• Oncology

Background:

• Multiple Endocrine Neoplasia Type 1 (MEN 1) is a genetic disorder leading to tumors in endocrine glands.
• Patients often develop endocrine issues before age 30 and have shorter lifespans.
• Predicting premature mortality in MEN 1 is crucial for patient management.

Purpose of the Study:

• To identify predictors of premature death in patients with Multiple Endocrine Neoplasia Type 1.
• To analyze the impact of early-onset endocrine abnormalities on survival rates.

Main Methods:

• Retrospective cohort study of 130 patients with a common MEN1 genotype.
• Kaplan-Meier survival analysis was used to determine median life expectancy (MLE).
• Analysis focused on the age of diagnosis for specific MEN 1-related conditions.

Main Results:

• Overall median life expectancy for the cohort was 70.8 years.
• Diagnoses before age 45 of adrenal nodularity, hypergastrinaemia, or liver lesions were linked to significantly reduced survival.
• Early diagnosis of pancreatic nodularity or primary hyperparathyroidism did not impact survival.

Conclusions:

• Patients with MEN 1 diagnosed before 45 with adrenal nodularity, hypergastrinaemia, or liver lesions face significantly reduced survival.
• The reasons for diminished life expectancy associated with non-secretory adrenal macronodular hyperplasia require further investigation.
• These findings emphasize the importance of early detection and management of specific MEN 1 manifestations.